This system will include an alarm to let you know when the glucose levels are out of bounds...but it is one of those "chips" that would need to be implanted...something to think about...BD
DexCom, Inc. (NASDAQ:DXCM) announced that it has received Food and Drug Administration (FDA) 
approval to calibrate the SEVENTM, its seven-day continuous glucose monitoring system, using any FDA cleared blood glucose meter. With this approval, patients will be able to calibrate the system without using a connection cable. DexCom expects to launch this feature to new patients near the end of the first quarter of 2008 and upgrade existing patients during the second quarter of 2008. 
- Tiny flexible Sensor goes under the skin
- Small Sensor — so small that it fits completely inside the insertion needle
- Smallest insertion needle (26 gauge) available
- Detachable, disposable applicator for easy and reliable insertion
Data is downloadable to computer for viewing of long-term trends DexComTM Receives FDA Approval To Calibrate Its SEVENTM Continuous Glucose Monitoring System Using Any FDA Cleared Blood Glucose Meter
Web Site: http://www.dexcom.com/html/dexcom_products.html
0 comments :
Post a Comment